Skip to main content

Table 4 Benefits total by score sociodemographic and clinical variables

From: The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country

Variable Frequency % N(300) Median (Q1–Q3) Mean ± SD Mean rank P value
Age category (years) < 0.001 b
  < 30 31 (10.3) 15.00(14.00–15.00) 14.55 ± 0.89 255.40
 30–60  163 (54.3) 12.00(11.00–14.00) 12.08 ± 1.97 159.84
  > 60 106 (35.3) 11.00(9.00–12.00) 10.69 ± 1.93 105.45
Gender 0.015 a
 Male  115 (38.3) 12.00(10.00–12.00) 11.47 ± 1.98 133.34
 Female  185 (61.7) 12.00(11.00–14.00) 12.07 ± 2.26 159.92
BMIa 0.003b
 Normal  65 (21.7) 12.00(11.00–15.00) 12.63 ± 2.08 178.75
 Overweight  136 (45.3) 12.00(10.00–13.00) 11.57 ± 2.30 139.13
 Obese  93 (31.0) 12.00(10.00–13.00) 11.58 ± 1.94 137.90
Education < 0.001 b
 Illiterate 20 (6.7) 9.50(9.00–11.00) 10.05 ± 1.57 75.45
 Elementary 43 (14.3) 11.00(9.00–12.00) 10.76 ± 1.76 101.92
 Primary 52 (17.3) 12.00(10.00–13.00) 11.73 ± 2.15 145.35
 Secondary 54 (18.0) 12.00(11.00–14.00) 12.19 ± 2.13 159.62
 University 124 (41.3) 12.00(11.00–15.00) 12.38 ± 2.15 166.65
Income (month) 0.641 b
 Less than 2000 NIS 23 (7.7) 12.00(11.00–15.00) 12.17 ± 2.61 160.98
 2000–5000 NIS 160(53.3) 12.00(11.00–14.00) 11.82 ± 2.20 145.83
 More than 5000 NIS 108(36.0) 12.00(10.00–13.00) 11.75 ± 2.09 143.06
locality 0.258 b
 Camp 36 (12.0) 12.00(11.00–14.75) 12.25 ± 2.08 161.86
 Rural 85(28.3) 12.00(11.00–15.00) 12.02 ± 2.30 153.71
 Urban 172(57.3) 12.00(10.00–13.00) 11.66 ± 2.14 140.58
Marital status 0.003 b
 Married 229(76.3) 12.00(11.00–14.00) 12.01 ± 2.14 127.51
 Unmarried (single, divorced, widowed) 67(22.3) 11.00(10.00–13.00) 11.37 ± 2.14 154.64
Employment status 0.188 a
 Employed 194(64.7) 12.00(10.00–13.25) 12.10 ± 1.80 156.46
 Unemployed 100(33.3) 12.00(11.00–14.00) 11.73 ± 2.32 142.88
Chronic co-morbid disease 0.018b
 No co-morbid disease 42 (14.0) 14.00(12.00–15.00) 12.14 ± 1.96 216.07
 One disease 44(14.7) 12.00(10.00–14.00) 11.99 ± 2.10 152.50
 Two diseases 63(21.0) 12.00(10.00–14.00) 12.05 ± 2.06 154.00
 Three diseases or more 146(48.7) 11.00(10.00–12.00) 11.20 ± 2.05 123.50
Indications for anticoagulant < 0.001 b
 Atrial fibrillation 63 (21.0) 11.00 (9.00–12.00) 10.84 ± 1.90 112.70  
 Deep vein thrombosis or Pulmonary embolism 29 (9.7) 12.00 (10.50–15.00) 12.31 ± 2.58 167.93  
 Prophylaxis c 72 (24.0) 13.00 (12.00–15.00) 13.11 ± 1.87 203.99
 Other indications 136 (45.3) 11.00 (10.00–12.75) 11.53 ± 2.03 135.98
Chronic medications < 0.001 a
  ≤4 176(58.7) 12.00(11.00–15.00) 12.25 ± 2.23 167.30
  > 4 124(41.3) 11.00(10.00–12.00) 11.26 ± 1.96 126.65
Anticoagulant drug < 0.001 a
 UHF 87(29) 11.00(10.00–12.00) 11.04 ± 1.74 113.63
 Vit-K dependent 134(44.7) 11.50(10.00–13.00) 11.52 ± 2.22 135.54
 NOACs 75(25) 13.00(12.00–15.00) 13.07 ± 1.89 198.53
  1. a The statistical significance of the differences was calculated using the Mann-Whitney U test
  2. b The statistical significance of the differences was calculated using the Kruskal-Wallis test
  3. Bold P-value indicates significant differences.c Patients that received prophylactic doses of unfractionated heparin during hospital admission
  4. NIS: New Israeli Shekel (0.29 US Dollar)